49 ICRAV 2026 NOTES JOINT SESSION 5 Animal anti-doping brings unique experiences, from dealing with multiple species to navigating the complexities of therapeutic medication use, which can enrich human anti-doping strategies. This presentation explores how deeper collaboration can address challenges and accelerate innovation. It invites the industry to think beyond traditional boundaries, exploring ideas including greater shared research efforts, cross-sport intelligence sharing, and use of AI-driven analytics and advanced reporting tools. It examines practical and structural barriers to integration, focusing on how equine anti-doping laboratories and regulators can contribute to, and benefit from, the wider global antidoping community—ensuring advances in analytical science, data capability, and governance flow in both directions. Breaking down silos and working across species, not only creates more resilient anti-doping systems but lays the groundwork for a truly innovative and sustainable future. This joined-up approach recognises that while sports may differ, the principles of fairness, welfare, and integrity are universal, and are best protected through shared solutions. By acknowledging these common foundations, through innovation, collaboration and globally coherent regulation we move towards anti-doping systems that not only deters wrongdoing but actively serves those athletes and stakeholders they exist to protect.
RkJQdWJsaXNoZXIy MTI3ODI1